RxDoctor Payments Data

Natella Rakhmanina

Pediatric Infectious Diseases · Washington, DCNPI 1043397524

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,452 of the $35,751 with a category attached, or 88.0%. Viiv Healthcare Company accounts for 72.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $21,714 and has fallen 99.8% since, to $52 in 2025.

$35,751in general payments, 2019–2025

Across 27 payments — averaging $1324.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$26K
  • Merck$7K
  • Gilead$3K
$396,843in research payments, 2019–2025

Across 83 payments — averaging $4781.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$265K
  • Merck$83K
  • Viiv Healthcare Company$46K
  • Pfizer$2K

What the payments were for

  • Consulting fees$31,45288%
  • Travel & lodging$3,51610%
  • Food & beverage$7832%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company14$25,996
Merck10$7,122
Gilead3$2,633

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in Washington

See the full list for District of Columbia →

Where these figures come from

Is this you, or does something look wrong? →